EKF Diagnostics will be exhibiting live and in person at Medica 2021 (Hall 3 Stand B71) for the first time in mainland Europe in two years.
EKF’s presence at this show will give visitors the opportunity to catch up with its industry specialists face-to-face and see the recently launched STAT-Site WB β-ketone and glucose handheld analyser on its first public viewing in Europe since its global launch earlier this year.
In Medica’s Hall 3, EKF will provide expert point-of-care diagnostics knowledge and advice. It will also demonstrate the globally successful PrimeStore MTM novel viral transport medium alongside the COVID-SeroKlir SARS-CoV-2 IgG antibody IVD kit, as well as showcase further new product innovations relating to the future control of COVID-19.
One of the world’s largest medical trade fairs, Medica will return to Düsseldorf on 15–18 November 2021 to highlight the best new and upcoming technologies in various sectors relating to clinical healthcare. To ensure the safety of visitors, there will be a plethora of COVID-19 safety measures in place, including proof of vaccination/recovery/negative test, ventilation, and sanitisation points.
As the first live exhibition attended by EKF Diagnostics in mainland Europe in two years, it will be a perfect opportunity to display the newly released STAT-Site WB. The dual-compound analyser allows for easy and quick (5–10 seconds respectively) glucose and β-ketone measurement from whole blood samples. This delivers clear and rapid analysis for diabetic patients displaying ketosis symptoms, thus enabling their rapid treatment.
Other EKF diabetes care products to be exhibited will be the Biosen C-Line Glucose and Lactate analyser. The device, which allows for the precise and efficient measurement of glucose and lactate in blood, can measure the analytes individually or together depending on the model. Also on show will be EKF’s Quo-Lab and Quo-Test HbA1c analysers for the point-of-care measurement of glycated haemoglobin to support immediate monitoring and management of diabetes patients.